Christopher Freeman
Vermögen: 8 Mio $ am 31.05.2026
Vermögen: 8 Mio $ am 31.05.2026
Christopher Freeman is Chief Commercial Officer at Guardant Health, Inc. since 2021.
Mr. Freeman is Member-National Board at Dream Foundation.
Mr. Freeman was Vice President at Gilead Sciences, Inc. from 2020 to 2021.
Mr. Freeman completed undergraduate education at US Military Academy and the University of Southern California.
Mr. Freeman completed graduate education at Central Michigan University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 61’101 ( 0.05% ) | 8 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GUARDANT HEALTH, INC. | Corporate Officer/Principal | 01.06.2021 |
Dream Foundation | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.06.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Guardant Health, Inc.
Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Central Michigan University
Central Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Military Academy
US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dream Foundation |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen